265 related articles for article (PubMed ID: 10352356)
1. Azoxymethane-induced aberrant crypt foci and colorectal tumors in F344 rats: sequential analysis of growth.
Ghirardi M; Nascimbeni R; Villanacci V; Fontana MG; Di Betta E; Salerni B
Eur Surg Res; 1999; 31(3):272-80. PubMed ID: 10352356
[TBL] [Abstract][Full Text] [Related]
2. Modulation of aberrant crypt foci by dietary fat and caloric restriction: the effects of delayed intervention.
Lasko CM; Bird RP
Cancer Epidemiol Biomarkers Prev; 1995; 4(1):49-55. PubMed ID: 7894324
[TBL] [Abstract][Full Text] [Related]
3. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the Apc gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats.
De Filippo C; Caderni G; Bazzicalupo M; Briani C; Giannini A; Fazi M; Dolara P
Br J Cancer; 1998 Jun; 77(12):2148-51. PubMed ID: 9649126
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous development of aberrant crypt foci in F344 rats.
Furukawa F; Nishikawa A; Kitahori Y; Tanakamaru Z; Hirose M
J Exp Clin Cancer Res; 2002 Jun; 21(2):197-201. PubMed ID: 12148578
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression.
Tessitore L; Davit A; Sarotto I; Caderni G
Carcinogenesis; 2000 Aug; 21(8):1619-22. PubMed ID: 10910967
[TBL] [Abstract][Full Text] [Related]
7. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
8. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
Rao CV; Hirose Y; Indranie C; Reddy BS
Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
[TBL] [Abstract][Full Text] [Related]
9. Termination of piroxicam treatment and the occurrence of azoxymethane-induced colon cancer in rats.
Li H; Kramer PM; Lubet RA; Steele VE; Kelloff GJ; Pereira MA
Cancer Lett; 1999 Dec; 147(1-2):187-93. PubMed ID: 10660105
[TBL] [Abstract][Full Text] [Related]
10. Aberrant crypt foci and colon cancer: comparison between a short- and medium-term bioassay for colon carcinogenesis using dimethylhydrazine in Wistar rats.
Rodrigues MA; Silva LA; Salvadori DM; De Camargo JL; Montenegro MR
Braz J Med Biol Res; 2002 Mar; 35(3):351-5. PubMed ID: 11887213
[TBL] [Abstract][Full Text] [Related]
11. The incidence of aberrant crypt foci and colonic carcinoma in dimethylhydrazine-treated rats varies in a site-specific manner and depends on tumor histology.
Park HS; Goodlad RA; Wright NA
Cancer Res; 1997 Oct; 57(20):4507-10. PubMed ID: 9377561
[TBL] [Abstract][Full Text] [Related]
12. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
Raju J; Patlolla JM; Swamy MV; Rao CV
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
[TBL] [Abstract][Full Text] [Related]
13. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
[TBL] [Abstract][Full Text] [Related]
14. Polyethylene-glycol suppresses colon cancer and causes dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats.
Parnaud G; Taché S; Peiffer G; Corpet DE
Cancer Res; 1999 Oct; 59(20):5143-7. PubMed ID: 10537289
[TBL] [Abstract][Full Text] [Related]
15. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen.
Whiteley LO; Hudson L; Pretlow TP
Toxicol Pathol; 1996; 24(6):681-9. PubMed ID: 8994294
[TBL] [Abstract][Full Text] [Related]
16. Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid.
Magnuson BA; Bird RP
Cancer Lett; 1993 Jan; 68(1):15-23. PubMed ID: 8422645
[TBL] [Abstract][Full Text] [Related]
17. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat.
Paulsen JE; Løberg EM; Olstørn HB; Knutsen H; Steffensen IL; Alexander J
Cancer Res; 2005 Jan; 65(1):121-9. PubMed ID: 15665287
[TBL] [Abstract][Full Text] [Related]
18. Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon.
Yamashita N; Minamoto T; Onda M; Esumi H
Jpn J Cancer Res; 1994 Jul; 85(7):692-8. PubMed ID: 7915263
[TBL] [Abstract][Full Text] [Related]
19. Progression of tumors arising from large ACF is associated with the MUC5AC expression during rat colon MNNG carcinogenis.
Maurin N; Forgue-Lafitte ME; Levy P; Zimber A; Bara J
Int J Cancer; 2007 Feb; 120(3):477-83. PubMed ID: 17066439
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
